ArticleMolecular therapy. Methods & clinical development2025
Structuring of lipid nanoparticle mRNA formulations at acidic and neutral pH: X-ray scattering and molecular dynamics studies.
Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Analytical Characterization and Stability Assessment of RNA-Based Vaccines.Pharmaceutics · 2026Review
- Effects of different mixing techniques on mRNA lipid nanoparticle physicochemistry and biological performance.Nature communications · 2026Article
- Formulation of Gamma-Oryzanol Encapsulated Nanoparticles and Their Modulation Effects on Inducible Nitric Oxide Synthase and Nitric Oxide in LPS-Stimulated RAW 264.7 Macrophages.Pharmaceutics · 2026Article
- Lipid nanoparticles for cell and gene therapy.Molecular therapy. Advances · 2026Article
- Decoding pH-Driven Phase Transition of Lipid Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
mRNA lipid nanoparticles (LNPs) effectively deliver mRNA into cells. However, the structure of these particles remains poorly understood. LNP formulations are manufactured by initially forming nanoparticles at pH 4, to incorporate the RNA, then adjusting the pH 7.4 to trap the RNA within. This work investigates the structural rearrangements that occur during this process. We used the Martini 2 coarse-grained force field to model LNPs with varying water content and placement of PEGylated lipids. New parameters were developed for the lipids Dlin-MC3-DMA, its ionized form and the PEGylated lipid DMG-PEG 2000. At pH 4, the simulations suggest that bilayers are formed at the aqueous interface of the LNPs, with a largely amorphous core, whereas at pH 7.4, the bulk of the LNP is amorphous. Based on our models, we estimate that LNPs contain less than 1% w/w water, with the RNA cargo residing at the interface between water clusters and lipids. RNA entrapment is enhanced when water clusters form inside LNPs. Small-angle X-ray scattering (SAXS) measurements of LNPs at the two modeled pH values are consistent with the MD simulations. This study provides insight into water cluster formation, lipid arrangement, and RNA distribution inside LNPs, advancing our understanding of mRNA-LNP formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.